Standard BioTools Inc. (NASDAQ: LAB) has entered into a definitive agreement to sell its Microfluidics business to ARCHIMED, a healthcare-focused ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions